Mutations in phosphoinositide-3-kinase (PI3K), catalytic, alpha polypeptide (PIK3CA), TP53, T cell factor 1 (TCF1), and WNT signaling pathway as well as AKT activation predict unfavorable outcomes of patients with HCC [8–11]. Here, TP53 is linked to hepatocellular carcinoma.